Disruption of sleep architecture in minimal hepatic encephalopathy and ghrelin secretion
暂无分享,去创建一个
C. Schubert | K. Saeian | J. Bajaj | J. Franco | C. Schubert | D. Heuman | R. Franco
[1] J. Pezzullo,et al. Randomised clinical trial: ghrelin agonist TZP‐101 relieves gastroparesis associated with severe nausea and vomiting – randomised clinical study subset data , 2011, Alimentary pharmacology & therapeutics.
[2] J S Bajaj,et al. Review article: the modern management of hepatic encephalopathy , 2010, Alimentary pharmacology & therapeutics.
[3] A. Sanyal,et al. Spectrum of neurocognitive impairment in cirrhosis: Implications for the assessment of hepatic encephalopathy , 2009, Hepatology.
[4] D. Skene,et al. Night‐time sleep disturbance does not correlate with neuropsychiatric impairment in patients with cirrhosis , 2009, Liver international : official journal of the International Association for the Study of the Liver.
[5] K. Spiegel,et al. Brief Communication: Sleep Curtailment in Healthy Young Men Is Associated with Decreased Leptin Levels, Elevated Ghrelin Levels, and Increased Hunger and Appetite , 2004, Annals of Internal Medicine.
[6] A. Steiger,et al. Ghrelin promotes slow-wave sleep in humans. , 2003, American journal of physiology. Endocrinology and metabolism.
[7] A. Lockwood,et al. Hepatic encephalopathy—Definition, nomenclature, diagnosis, and quantification: Final report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna, 1998 , 2002, Hepatology.
[8] M. Nakazato,et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach , 1999, Nature.
[9] P. Penev,et al. High prevalence of sleep disturbance in cirrhosis , 1998, Hepatology.